GlobeNewswire

Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time
10/03/2026
Live Webcast on Thursday, March 19 at 8:40 am ET to Highlight the Expanding Clinical Experience with the LIBERTY® Endovascular Robotic System During the Limited Market Release HINGHAM, Mass., March 10, 2026 (GLOBE [...]
Celularity Secures $35 Million Strategic License Deal, Strengthens Capital Position to Advance Longevity-Focused Strategy
10/03/2026
Transaction expected to generate up to $35 million in upfront and milestone payments Celularity retains exclusive manufacturing rights, creating continued biomaterials revenue and margin opportunity Organizational [...]
SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results
10/03/2026
Strong growth in SSi Mantra installations, procedures and revenues FORT LAUDERDALE, Fla., March 10, 2026 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII) , a [...]
Natural Remedies Advances Sleep Health Research with Holixer During National Sleep Awareness Month
10/03/2026
BANGALORE, India, March 10, 2026 (GLOBE NEWSWIRE) -- During National Sleep Awareness Month in March, Natural Remedies is highlighting human clinical research on Holixer , a standardized holy basil extract, that applies [...]
NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimer’s Disease at AD/PD™ 2026
10/03/2026
SANTA ANA, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative [...]
API Innovation Center Highlights Fragility in U.S. Drug Supply Chain in New White Paper
10/03/2026
Report outlines how measuring supply chain fragility can guide policy, investment and procurement reform ST. LOUIS, March 10, 2026 (GLOBE NEWSWIRE) -- The API Innovation Center (APIIC), a nonprofit dedicated to [...]
Glucotrack to Present at LSI USA ’26 Medtech Innovation Summit
10/03/2026
RUTHERFORD, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc.(“Glucotrack”, or the “Company”) (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel [...]
Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
10/03/2026
Reported interim data from ADVANCED-2 trial in non-muscle invasive bladder cancer (NMIBC); TARA-002 demonstrated 68% complete response rate at six months in BCG-Unresponsive patients Company expects to complete [...]
Tonix Pharmaceuticals Presented Post Hoc Analyses of Phase 3 Data on TONMYATM at the 8th International Congress on Controversies in Fibromyalgia
10/03/2026
Company launched TONMYA, approved by the FDA as a treatment for fibromyalgia, in November 2025 In post hoc analysis of the pivotal RESILIENT study, TONMYA produced rapid pain relief as early as Day 2 of treatment, with [...]
electroCore to Participate at the 38th Annual Roth Conference
10/03/2026
ROCKAWAY, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, announced today that management will participate in the 38th Annual Roth Conference [...]
Aspargo Labs Gears Up to Bring Patented Liquid Erectile Dysfunction Treatment to UK Over-the-Counter Pharmacy Shelves
10/03/2026
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. (“Aspargo Labs” or the “Company”), a pharmaceutical company commercializing an oral suspension spray technology, today announced it has submitted an [...]
Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results
10/03/2026
Record full-year total revenue and AVISE ® CTD average selling price New biomarkers and sales force expansion drove over 11% full-year test volume growth CARLSBAD, Calif., March 10, 2026 (GLOBE NEWSWIRE) -- Exagen Inc [...]
Daxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care Congress
10/03/2026
Advancing Precision Fluid Management in the ICU to Reduce Mortality and Hospital Length of Stay Oak Ridge, TN, March 10, 2026 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR) , the global leader in blood volume [...]
New Report, “Let’s Talk Poop: Digestive Health, Denial, and the Cost of Staying Quiet,” Reveals Widespread Digestive Health Issues Accompanied By Stigma and Embarrassment
10/03/2026
National data from Oshi Health reveals that 50% of Americans have gut issues, but a majority simply think treatable symptoms are normal and don’t want to talk about them NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- A [...]
VTAK Announces Definitive Merger Agreement to Acquire 100% of Fly Flyte Inc.
10/03/2026
Transaction Delivers Wholly Owned, Scalable Asset-Backed, Aviation Platform with Accelerating Revenue and Consolidated Control Positions VTAK at the Center of High-Growth Regional Air Mobility Ahead of Industry-Wide [...]
BioNTech and Co-Founders Announce Plan to Pursue Next-Generation mRNA Innovations in Co-Founders-Led New Company as BioNTech Advances Toward Becoming a Multi-Product Company by 2030
10/03/2026
BioNTech continues to sharpen its strategic focus on the growing late-stage clinical pipeline spanning immunomodulator, ADC and mRNA candidates BioNTech co-founders Ugur Sahin and Özlem Türeci will establish an [...]
EVAA.AI Expands to Integrate with Multiple Eye Care EHR Systems
10/03/2026
Eye care practices can now access EVAA’s AI-powered billing automation and clinical documentation tools without changing their existing EHR system PORTLAND, Ore., March 10, 2026 (GLOBE NEWSWIRE) -- EVAA.AI , part of the [...]
BPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 Meeting; AtaiBeckley Highlights Key Pipeline Milestones at 2026 Investor Day
10/03/2026
BPL‑003 holds Breakthrough Therapy Designation and is supported by positive Phase 2b results in treatment-resistant depression Cash runway reaffirmed through the planned early-2029 topline readouts from both parallel [...]
MiNK Therapeutics Announces Collaboration with C-Further to Advance PRAME-Targeted iNKT Cell Therapy for Pediatric Cancers
10/03/2026
Selected as a C-Further program with up to ~$1.1 million in non-dilutive, aggregate payments to advance IND-enabling development, with potential for meaningful double-digit downstream commercial revenue participation [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum